These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20104485)

  • 1. Early diagnosis of primary nonfunction and indication for reoperation after liver transplantation.
    Lock JF; Schwabauer E; Martus P; Videv N; Pratschke J; Malinowski M; Neuhaus P; Stockmann M
    Liver Transpl; 2010 Feb; 16(2):172-80. PubMed ID: 20104485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limitations of use of the noninvasive clearance of indocyanine green as a prognostic indicator of graft function in liver transplantation.
    Escorsell À; Mas A; Fernández J; García-Valdecasas JC
    Transplant Proc; 2012; 44(6):1539-41. PubMed ID: 22841207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to define initial poor graft function after liver transplantation? - a new functional definition by the LiMAx test.
    Stockmann M; Lock JF; Malinowski M; Seehofer D; Puhl G; Pratschke J; Neuhaus P
    Transpl Int; 2010 Oct; 23(10):1023-32. PubMed ID: 20444241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial liver graft function is a reliable predictor of tacrolimus trough levels during the first post-transplant week.
    Lock JF; Malinowski M; Schwabauer E; Martus P; Pratschke J; Seehofer D; Puhl G; Neuhaus P; Stockmann M
    Clin Transplant; 2011; 25(3):436-43. PubMed ID: 20482563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early noninvasive measurement of the indocyanine green plasma disappearance rate accurately predicts early graft dysfunction and mortality after deceased donor liver transplantation.
    Olmedilla L; Pérez-Peña JM; Ripoll C; Garutti I; de Diego R; Salcedo M; Jiménez C; Bañares R
    Liver Transpl; 2009 Oct; 15(10):1247-53. PubMed ID: 19790138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity.
    Stockmann M; Lock JF; Riecke B; Heyne K; Martus P; Fricke M; Lehmann S; Niehues SM; Schwabe M; Lemke AJ; Neuhaus P
    Ann Surg; 2009 Jul; 250(1):119-25. PubMed ID: 19561474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection.
    Neff GW; O'Brien CB; Nery J; Shire NJ; Nishida S; delaGarza J; Montalbano M; Safdar K; Ruiz P; Rideman E; Gascon JA; Tzakis AG; Madariaga J; Rudich SM
    Liver Transpl; 2004 Dec; 10(12):1497-503. PubMed ID: 15558835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of graft dysfunction after orthotopic liver transplantation in man by serum and biliary bile acid analysis.
    Baumgartner U; Schölmerich J; Kremer B; Streckfuss G; Henne-Bruns D; Mergard BL; Kraemer-Hansen H; Farthmann EH
    Hepatogastroenterology; 1995; 42(6):950-60. PubMed ID: 8847051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation.
    Levesque E; Saliba F; Benhamida S; Ichaï P; Azoulay D; Adam R; Castaing D; Samuel D
    Liver Transpl; 2009 Oct; 15(10):1358-64. PubMed ID: 19790157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indocyanine green elimination but not bilirubin indicates improvement of graft function during MARS therapy.
    Scheingraber S; Richter S; Igna D; Girndt M; Flesch S; Kleinschmidt S; Schilling MK
    Clin Transplant; 2007; 21(6):689-95. PubMed ID: 17988260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-center experience with retrograde reperfusion in liver transplantation.
    Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Stadlbauer V; Tscheliessnigg KH
    Transpl Int; 2003 Oct; 16(10):730-5. PubMed ID: 12819865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cholestasis markers as predictors of early outcome after liver transplantation.
    Ben-Ari Z; Weiss-Schmilovitz H; Sulkes J; Brown M; Bar-Nathan N; Shaharabani E; Yussim A; Shapira Z; Tur-Kaspa R; Mor E
    Clin Transplant; 2004 Apr; 18(2):130-6. PubMed ID: 15016125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the prognosis in acute liver failure: results from a retrospective pilot study using the LiMAx test.
    Lock JF; Kotobi AN; Malinowski M; Schulz A; Jara M; Neuhaus P; Stockmann M
    Ann Hepatol; 2013; 12(4):556-62. PubMed ID: 23813133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience.
    Uemura T; Randall HB; Sanchez EQ; Ikegami T; Narasimhan G; McKenna GJ; Chinnakotla S; Levy MF; Goldstein RM; Klintmalm GB
    Liver Transpl; 2007 Feb; 13(2):227-33. PubMed ID: 17256780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and criteria predicting early graft loss after adult-to-adult living donor liver transplantation.
    Du Z; Wei Y; Chen K; Chen X; Zhang Z; Li H; Ma Y; Li B
    J Surg Res; 2014 Apr; 187(2):673-82. PubMed ID: 24275573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
    Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of early liver graft performance by the indocyanine green plasma disappearance rate.
    Stockmann M; Lock JF; Malinowski M; Neuhaus P
    Liver Transpl; 2010 Jun; 16(6):793-4; author reply 795-6. PubMed ID: 20517918
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.
    Gaspari R; Cavaliere F; Sollazzi L; Perilli V; Melchionda I; Agnes S; Gasbarrini A; Avolio AW
    Transplant Proc; 2009; 41(1):253-8. PubMed ID: 19249528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized comparison of intraoperative indocyanine green angiography and transit-time flow measurement to detect technical errors in coronary bypass grafts.
    Desai ND; Miwa S; Kodama D; Koyama T; Cohen G; Pelletier MP; Cohen EA; Christakis GT; Goldman BS; Fremes SE
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):585-94. PubMed ID: 16935114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.